EDGAR Filing Documents for 0001144204-15-049282

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-15-049282

Filing Date

2015-08-14

Accepted

2015-08-14 08:21:36

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	v418191_10q.htm	10-Q	266955
2	EXHIBIT 10.1	v418191_ex10-1.htm	EX-10.1	536571
3	EXHIBIT 10.4	v418191_ex10-4.htm	EX-10.4	29503
4	EXHIBIT 10.5	v418191_ex10-5.htm	EX-10.5	227716
5	EXHIBIT 31.1	v418191_ex31-1.htm	EX-31.1	10408
6	EXHIBIT 31.2	v418191_ex31-2.htm	EX-31.2	10636
7	EXHIBIT 32.1	v418191_ex32-1.htm	EX-32.1	4411
8	EXHIBIT 32.2	v418191_ex32-2.htm	EX-32.2	4416
9	GRAPHIC	tpg06.jpg	GRAPHIC	99815
	Complete submission text file	0001144204-15-049282.txt		1229532

Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219

Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100

ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)